Вы искали: hipovolemija (Словенский - Английский)

hipovolemija
volume depletion

znotrajžilna hipovolemija
intravascular hypovolaemia

anoreksija, zmanjšan apetit, elektrolitsko neravnovesje, hiperholesterolemija, hiperglikemija, hipovolemija
anorexia, appetite decreased, electrolyte imbalance, hypercholesterolaemia, hyperglycaemia, hypovolaemia

previdnost je potrebna tudi pri bolnikih, ki dobivajo diuretike ali jih sicer ogroža hipovolemija.
caution is also required in patients taking diuretic treatment or otherwise at risk of hypovolaemia.

previdnost je potrebna tudi pri bolnikih, ki prejemajo diuretike ali jih kako drugače ogroža hipovolemija.
caution is also required in patients taking diuretic treatment or otherwise at risk of hypovolaemia.

neznana: anoreksija, zmanjšan apetit, elektrolitsko neravnovesje, hiperholesterolemija, hiperglikemija, hipovolemija
not known: anorexia, appetite decreased, electrolyte imbalance, hypercholesterolaemia, hyperglycaemia, hypovolaemia

ugotovili so, da je bil primarni dejavnik tveganja dehidracija in/ali hipovolemija zaradi toksičnosti za prebavila.
the primary risk factor identified was dehydration and/or hypovolemia due to gastrointestinal toxicity.

pred vsakim infundiranjem zdravila removab je treba odpraviti stanja kot so hipovolemija, hipoproteinemija, hipotenzija, cirkulatorna dekompenzacija in okvara delovanja ledvic.
conditions such as hypovolaemia, hypoproteinaemia, hypotension, circulatory decompensation and acute renal impairment must be resolved prior to each removab infusion.

19 hipovolemija pri bolnikih s hipovolemijo ali pomanjkanjem natrija zaradi intenzivnega diuretičnega zdravljenja, omejenega vnosa soli s hrano, driske ali bruhanja, lahko pride do simptomatske hipotenzije.
intravascular volume depletion symptomatic hypotension may occur in patients who are volume and/ or sodium depleted as a result of vigorous diuretic therapy, dietary salt restriction, diarrhoea or vomiting.

v večini primerov so ugotovili dejavnike tveganja, kot so obstoječa ledvična insuficienca, sladkorna bolezen, hipovolemija, debelost, sočasno jemanje nefrotoksičnih zdravil ali starost nad 65 let.
in most cases risk factors have been identified, such as pre-existing renal insufficiency, diabetes mellitus, hypovolaemia, overweight, concomitant nephrotoxic medicinal products or age over 65.

delovanje ledvic je treba oceniti tudi, če se med zdravljenjem pojavi sum na spremembo v delovanju ledvic (npr. hipovolemija, dehidracija in sočasna uporaba določenih zdravil).
renal function should also be assessed when a change in renal function is suspected during treatment (e.g. hypovolaemia, dehydration, and in case of concomitant use of certain medicinal products).

obstajajo posamezna poročila o naslednjih neželenih učinkih: depresija kostnega mozga, znižan protrombin, znižan gonadotropni luteinizirajoči hormon, zvišana amilaza, hiponatremija, hipokaliemija, hiperurikemija, hiperholesterolemija, hiperlipemija, hipomagneziemija, nenormalna hoja, stupor, cirkumoralna parestezija, nenormalno mišljenje, bolečine v očeh, hipovolemija, subduralni hematom, srčno popuščanje, palpitacije, epistaksa, vaskularne anomalije, žilne bolezni, bledica, pljučnica, bolezni dihalnih poti, bolezni pljuč, plevralne motnje, holecistitis, okvara jeter, zlatenica, obstruktivna zlatenica, melena, bruhanje, laringospazem, tenezmi, rinitis, povečan apetit, gingivitis, pasavec, psoriaza, furunkuloza, kontaktni dermatitis, seboreja, lihenoidni dermatitis, artritis, bolezni sklepov, zastoj seča, moteno uriniranje, poliurija, nikturíja, impotenca, nenormalnosti seča, povečanje obsega prsi, karcinom, preobčutljivost za svetlobo, edem obraza, občutek slabosti, virusna okužba in povečan trebuh.
single observations of the following were also reported: bone marrow depression, decreased prothrombin, decreased gonadotrophic luteinizing hormone, increased amylase, hyponatraemia, hypokalaemia, hyperuricaemia, hypocholesterolaemia, hypolipaemia, hypomagnesaemia, abnormal gait, stupor, circumoral paraesthesia, abnormal thinking, eye pain, hypovolaemia, subdural haematoma, congestive heart failure, palpitation, epistaxis, vascular anomaly, vascular disorder, pallor, pneumonia, respiratory disorder, lung disorder, pleural disorder, cholecystitis, liver damage, jaundice, cholestatic jaundice, melaena, vomiting, laryngismus, tenesmus, rhinitis, increased appetite, gingivitis, herpes zoster, psoriasis, furunculosis, contact dermatitis, seborrhoea, lichenoid dermatitis, arthritis, joint disorder, urinary retention, impaired urination, polyuria, nocturia, impotence, urine abnormality, breast enlargement, carcinoma, photosensitivity reaction, face oedema, malaise, viral infection, enlarged abdomen.